Pericytes Favor Oligodendrocyte Fate Choice in Adult Neural Stem Cells. by Silva, Maria Elena et al.
BRIEF RESEARCH REPORT
published: 27 March 2019
doi: 10.3389/fncel.2019.00085
Edited by:
Mauricio Antonio Retamal,
Universidad del Desarrollo, Chile
Reviewed by:
Liuqing Yang,
Johns Hopkins Medicine,
United States
Laura Andrea Pasquini,
Consejo Nacional de Investigaciones
Científicas y Técnicas (CONICET),
Argentina
Annalisa Buffo,
University of Turin, Italy
*Correspondence:
Francisco J. Rivera
francisco.rivera@uach.cl
†Shared first authorship
‡Present Address:
Alerie Guzman de la Fuente,
Wellcome-Wolfson Centre for
Experimental Medicine, Queen’s
University Belfast, Belfast,
United Kingdom
Received: 15 September 2018
Accepted: 20 February 2019
Published: 27 March 2019
Citation:
Silva ME, Lange S, Hinrichsen B,
Philp AR, Reyes CR, Halabi D,
Mansilla JB, Rotheneichner P,
Guzman de la Fuente A,
Couillard-Despres S, Bátiz LF,
Franklin RJM, Aigner L and Rivera FJ
(2019) Pericytes Favor
Oligodendrocyte Fate Choice in Adult
Neural Stem Cells.
Front. Cell. Neurosci. 13:85.
doi: 10.3389/fncel.2019.00085
Pericytes Favor Oligodendrocyte
Fate Choice in Adult Neural Stem
Cells
Maria Elena Silva1,2,3†, Simona Lange4,5†, Bryan Hinrichsen1,2†, Amber R. Philp1,2†,
Carolina R. Reyes1,2, Diego Halabi1,2, Josselyne B. Mansilla1,2, Peter Rotheneichner5,6,
Alerie Guzman de la Fuente7‡, Sebastien Couillard-Despres5,6,8, Luis F. Bátiz9,
Robin J. M. Franklin7, Ludwig Aigner4,5,8 and Francisco J. Rivera1,2,4,5*
1Laboratory of Stem Cells and Neuroregeneration, Institute of Anatomy, Histology and Pathology, Faculty of Medicine,
Universidad Austral de Chile, Valdivia, Chile, 2Center for Interdisciplinary Studies on the Nervous System (CISNe), Universidad
Austral de Chile, Valdivia, Chile, 3Institute of Pharmacy, Faculty of Sciences, Universidad Austral de Chile, Valdivia, Chile,
4Institute of Molecular Regenerative Medicine, Paracelsus Medical University, Salzburg, Austria, 5Spinal Cord Injury and
Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, Salzburg, Austria, 6Institute of
Experimental Neuroregeneration, Paracelsus Medical University Salzburg, Salzburg, Austria, 7Wellcome Trust and Medical
Research Council (MRC) Cambridge Stem Cell Institute & Department of Clinical Neurosciences, University of Cambridge,
Cambridge, United Kingdom, 8Austrian Cluster for Tissue Regeneration, Vienna, Austria, 9Centro de Investigación Biomédica
(CIB), Facultad de Medicina, Universidad de los Andes, Santiago, Chile
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central
nervous system (CNS). Upon demyelination, oligodendrocyte progenitor cells
(OPCs) are activated and they proliferate, migrate and differentiate into myelin-
producing oligodendrocytes. Besides OPCs, neural stem cells (NSCs) may respond
to demyelination and generate oligodendrocytes. We have recently shown that
CNS-resident pericytes (PCs) respond to demyelination, proliferate and secrete Laminin
alpha2 (Lama2) that, in turn, enhances OPC differentiation. Here, we aimed to evaluate
whether PCs influence the fate choice of NSCs in vitro, towards the production of
new myelin-producing cells. Indeed, upon exposure to conditioned medium derived
from PCs (PC-CM), the majority of NSCs gave rise to GalC- and myelin basic protein
(MBP)-expressing oligodendrocytes at the expense of the generation of GFAP-positive
astrocytes. Consistent with these findings, PC-CM induces an increase in the expression
of the oligodendrocyte fate determinant Olig2, while the expression level of the astrocyte
determinant ID2 is decreased. Finally, pre-incubation of PC-CM with an anti-Lama2
antibody prevented the generation of oligodendrocytes. Our findings indicate that
PCs-derived Lama2 instructs NSCs to an oligodendrocyte fate choice favoring the
generation of myelin-producing cells at the expense of astrocytes in vitro. Further
studies aiming to reveal the role of PCs during remyelination may pave the way for the
development of new therapies for the treatment of MS.
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INTRODUCTION
In multiple sclerosis (MS) myelin loss within the central nervous system (CNS) represents a crucial
pathological event that, when persistent, results in irreversible axonal death leading to a decline
in neurological function. Myelin sheaths are restored through a process known as remyelination,
which is feasible due to the presence of CNS-resident oligodendrocyte progenitor cells (OPCs).
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Upon demyelination, OPCs become activated and they
proliferate, migrate, and differentiate into remyelinating
oligodendrocytes (Franklin and ffrench-Constant, 2008;
Zawadzka et al., 2010). Although this spontaneous reparative
phenomenon is quite robust, it often fails in the more advanced
stages of MS (Blakemore, 1974; Wolswijk, 1998). Thus, revealing
the mechanisms that underlie OPC-mediated remyelination
or exploring alternative remyelination sources in the CNS
might provide insights for the development of regenerative
MS therapies.
Several studies have identified positive and negative regulators
of myelin repair such as, secreted growth factors, members
of the extracellular matrix (ECM) as well as cells from the
non-oligodendroglial lineage (Rivera et al., 2010). There is
increasing evidence that pericytes (PCs) might have essential
functions in CNS repair and, particularly during remyelination.
PCs are perivascular cells located at the abluminal surface of
capillaries that regulate angiogenesis, endothelial cell function
and control microvascular blood flow (Armulik et al., 2010).
Within the CNS, pericytes are essential for the proper
stability and function of the blood-brain-barrier (BBB; Winkler
et al., 2011). We have recently demonstrated that after
demyelination, PCs promote oligodendroglial differentiation
of OPCs through the expression/secretion of Laminin alpha
2 (Lama2; De La Fuente et al., 2017). We now aim to
explore if PCs might also influence other CNS-resident
progenitor cells.
OPCs are not the only source of oligodendrocytes. Adult
neural stem cells (NSCs) located in specific neurogenic niches
respond to demyelination and contribute to the generation of
new oligodendrocytes. In response to myelin loss, CNS-resident
NSCs proliferate and give rise to Olig2-expressing cells
that migrate towards the lesion site and differentiate into
oligodendrocytes (Nait-Oumesmar et al., 1999; Menn et al.,
2006; Etxeberria et al., 2010; Jablonska et al., 2010; Kazanis
et al., 2017). Although there is compelling evidence showing
that adult NSCs may change their neurogenic fate towards
the generation of oligodendrocytes, the molecular and cellular
mechanisms that enable this phenomenon, however, remain
elusive. Here, we examined the possibility of soluble factors
derived from PCs (particularly, Lama2) to induce adult NSCs to
generate oligodendrocytes.
MATERIALS AND METHODS
Preparation of Primary CNS Pericytes
Preparation was performed as in De La Fuente et al. (2017).
Briefly, rat primary PCs were isolated from 6–8 weeks old
female Fisher 344 rats. Brains were collected in ice cold
alphaMEM (Gibco). Meninges were removed and brains were
minced in alphaMEM and overlayed on a cold 15% dextran
solution and centrifuged at 5,000 g at 4◦C for 10 min. Pellet
containing cerebral vessels was collected, washed, resuspended
in alphaMEM, and then filtered through a 150 µm mesh.
The flow-through was again filtered through a 40 µm mesh
to eliminate single cells. Microvessels were then collected
and digested in a waterbath for 30 min at 37◦C. Digested
microvessels were centrifuged (1,000 g, 10 min), cells were
cultured in alphaMEM containing 20% FBS (Gibco) and 1%
Penicillin/ Streptomycin (Thermo Fisher, Waltham, MA, USA)
in a humidifying incubator (20%O2, 5% CO2 at 37◦C). After first
passage cells were incubated in alphaMEM containing 10% FBS.
Expanded cells displayed a typical PC marker expression profile,
confirming the identity and purity of this culture (Figure 1A).
Preparation of Primary Neural Stem Cells
Rat-derived hippocampal NSC preparation was performed as
previously described (Wachs et al., 2003). Briefly, 6–8 weeks
old female Fisher 344 rats were anesthetized with Isofluran
and subsequently decapitated. Hippocampus were dissected and
collected in ice cold DPBS/glu. Brain regions were minced and
enzymatically digested, washed, and cultured in NBA medium
(Gibco) containing EGF and FGF for sphere formation. Five rats
were used for one preparation. After preparation, NSCs were
cultured in T25 flasks in a humidifying incubator (20% O2, 5%
CO2 at 37◦C).
NSC Stimulation With PC-CM and
MSC-CM
NSCs were treated with PC-CM and MSC-CM as previously
described (Rivera et al., 2006). Briefly, NSCs were seeded
overnight onto poly-ornithine (250 µg/mL) and laminin
(5µg/mL)-coated glass coverslips at a density of 12,000 cells/cm2
in αMEM-10% FBS. Next, media was replaced, and cells
were incubated either with PC-CM or MSC-CM. NSCs were
alternatively incubated in αMEM-10% FBS as a control
condition. Media was changed every third day. After 1 week of
incubation, cells were fixed for 10 min with phosphate-buffered
4% paraformaldehyde (Sigma-Aldrich, Taufkirchen, Germany)
and processed for immunofluorescence.
Blocking of Lama2 in PC-CM
PC-CMwas collected as previously described (De La Fuente et al.,
2017). To block Lama2 in the PC-CM, the media was incubated
in rotation for 2 h at room temperature and covered from light
with 1:50 dilution of either general rabbit IgG antibody (Cell
Signaling, 2729S) or rabbit anti-Lama2 antibody (Santa Cruz,
SC-20412). Upon incubation, the NSC medium was replaced
by the PC-CM (pre-incubated with the different antibodies).
This process was repeated after 3 days of stimulation and the
experiment was stopped at 7 days of incubation.
Immunocytochemistry
Immunocytochemical stainings were performed as previously
described (Steffenhagen et al., 2012). The following antibodies
and dilutions were used. Primary antibodies: rabbit anti-GFAP
1:1,000 (Dako, Denmark); mouse anti-myelin basic protein
(anti-MBP) 1:750 (SMI-94, Covance, Anopoli Biomedical
Systems, Eichgraben, Austria); rabbit anti-Galactocerebroside
(GalC) 1:200 (Millipore, Burlington, MA, USA); rabbit anti Ki67
1:500 (Thermos Sc.); goat anti olig2 1:200 (Abcam); Secondary
antibodies: donkey anti-mouse, rabbit, goat conjugated with
Alexa Fluor 488, Alexa 568 1:1,000 (Molecular Probes, Eugene,
OR, USA). Nuclear counterstaining was performed with
4′,6′-diamidino-2-phenylindole dihydrochloride hydrate at
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FIGURE 1 | Pericytes (PCs) promote oligodendrocyte differentiation in adult neural stem cells (NSCs). (A) Table shows the qualitative profile expression of cell
markers in PC cultures (B) Schematic representation of the experimental design. (C) Fluorescence images displaying GFAP+/myelin basic protein (MBP+) cells after
7 days and (D) their respective graph. Scale bars in (B) = 100 µm. Note the increase in the percentage of MBP-expressing oligodendrocytes and the reduction in the
proportion of GFAP+ astrocytes when NSCs were exposed to PC-CM. Quantitative PCR analysis of the expression of (E) glial fate determinants (Olig2 for
oligodendrocytes and ID2 for astrocytes) and of (F) the neurogenic marker doublecortin (DCX). Note that PC-CM increases the expression of Olig2 and decreases
ID2 while DCX was not affected. Means ± SD are shown. Data were obtained from three independent experiments and were analyzed by analysis of variance
(ANOVA) followed by Tukey post hoc test. ∗∗p < 0.01, ### and ∗∗∗p < 0.001. ∗ Indicates statistical difference for PC-CM and # for MSC-CM. (G) Graph of MTT
proliferation assay after incubation with alfa MEM (Ctrl) and PC-CM during 0, 24 and 48 h showing that there are no significant differences between the two
conditions. (H,I) Quantitative analysis of Ki-67 + Olig2+ cells compared to the total population of Olig2 + cells 2 and 4 days after incubation with alfa MEM (Ctrl) and
PC-CM. Data show that there are no significant differences between the two conditions and the two time points considered; ns, not significant.
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0.25 µg/µl (DAPI; Sigma, Germany). For more details see
Supplementary Materials.
Statistical Analysis
Data are presented as means ± SD and statistical analysis
was performed using PRISM4 (GraphPad, San Diego, CA,
USA). P values of < 0.05 were considered significant. Data
from Figures 1D–G were analyzed using a one-way analysis
of variance (ANOVA) and Tukey post hoc considering three
biologically independent experiments. Data from Figures 1H,I
were analyzed using an unpaired t-test. Data from Figure 2
were analyzed using a two-way ANOVA (uncorrected Fisher’s
LSD) considering five biologically independent experiments
which were performed in technical triplicate. Data from
Figures 1H,I were analyzed using an unpaired t-test. Each
biological experiment was performed in technical triplicates.
RESULTS
Soluble Factors Released by PCs Induce
Oligodendrocyte Fate Decision on Adult
NSCs
Since mesenchymal stem cells (MSCs) secrete soluble factors
that instruct oligodendrocyte fate choice in adult NSCs (Rivera
et al., 2006) and PCs display similar cellular features to MSCs
(Crisan et al., 2008), we evaluated whether conditioned medium
derived from PCs (PC-CM) also influences NSC function.
Conditioned medium derived from MSCs (MSC-CM) was
used as positive control (Rivera et al., 2006; De La Fuente
et al., 2017). PC-CM significantly induced the expression of
oligodendroglial markers in adult NSCs cultures. After 7 days
of exposure to PC-CM, 49 ± 6% of the NSCs were positive
for MBP while only 5 ± 2% were positive under control
FIGURE 2 | PC-derived Laminin alpha2 (Lama2) induces oligodendrocyte fate decision NSCs. (A) NSCs were cultured for seven days with control media or PC-CM
that, alternatively, were pre-treated with the addition of general Rabbit-IgG or anti-Lama2 anti-bodies. (B) Percentage of GFAP-expressing astrocytes (n = 5) and
MBP+ oligodendrocytes (n = 5) according to the treatment depicted in (A). Scale bars, 100 µm. Note that the anti-Lama2 antibody blocks the oligodendrogenic
effect and suppresses the astrogenic inhibition induced by PC-CM in NSCs. Means ± SD are shown. Data were obtained from two independent experiments and
were analyzed by two-way ANOVA (uncorrected Fisher’s LSD). ∗p < 0.05, ∗∗∗p < 0.001 compared to the respective untreated media control; ns, not significant.
Frontiers in Cellular Neuroscience | www.frontiersin.org 4 March 2019 | Volume 13 | Article 85
Silva et al. Pericytes Promote Oligodendrogenesis in NSCs in vitro
conditions (Figures 1B–D). Similarly, PC-CM elevated the
percentage of GalC positive cells in NSCs. There was no
statistical difference between the proportion of GalC+ and
MBP-expressing cells, suggesting that PC-CM promotes the
generation of fully differentiated oligodendrocytes. Nevertheless,
it seems that MSC-CM displays a stronger oligodendrogenic
effect on NSCs since more MBP-expressing cells are generated
compared to PC-CM. This increase in oligodendrogenesis
induced by PC-CM was accompanied by a significant decrease
in the generation of GFAP-expressing astrocytes compared
to control conditions. mRNA expression analyses of the glial
fate determinants Olig2 and Id2 (Samanta and Kessler, 2004;
Steffenhagen et al., 2012) by qRT-PCR supported these findings.
Upon 3 days of exposure to PC-CM, there was a significant
increase in Olig2 mRNA expression (3.8 ± 1.2-fold) as well
as a reduction in mRNA expression levels of the astrocyte
determinant Id2 (0.4± 0.1-fold) compared to control conditions
(Figure 1D). PC-CM also reduced neuronal fate in NSCs,
since doublecortin (DCX) mRNA expression was significantly
decreased (0.4 ± 0.1) relative to control conditions (Figure 1E).
These data indicate that soluble factors derived from PCs
induce an oligodendrocyte fate in adult NSCs at the expense
of astroglial and neuronal fate. However, this increase in the
generation of oligodendrocytes induced by PC-CM may be
due to an indirect effect on cell viability/proliferation. To
exclude this possibility, we performed an MTT assay and
found no differences between PC-CM and control conditions
(Figure 1G). In addition, to discard that PC-CMmay specifically
increase the proliferation of NSC-derived oligodendrocytes we
evaluated the proportion of Ki67+ cells among the Olig2-
expressing population and found no differences between the
tested conditions (Figures 1H,I). Together, these data indicate
that soluble factors derived from PCs do not affect cell
viability/proliferation but directly favor oligodendrocyte fate
choice and differentiation of NSCs.
PCs-Derived Lama2 Favors
Oligodendrocyte Differentiation at Expense
of Astrogenesis in NSCs
Since we have previously shown that Lama2 secreted by PCs
enhances OPC differentiation during remyelination (De La
Fuente et al., 2017), we tested whether Lama2 is also responsible
for the oligodendrocyte fate choice induced by PCs in NSCs.
As observed in Figure 1, treatment of NSCs with PC-CM
induced oligodendrocyte fate choice, however, pre-treatment of
PC-CMwith an anti-Lama2 blocking antibody led to a significant
reduction in MBP-expressing oligodendrocytes compared to
the PC-CM media control (11.7 ± 9.5% vs. 56.9 ± 12.9%
respectively) and a significant increase in the percentage of
GFAP+ astrocytes (44, 7 ± 25.0% vs. 7.5 ± 3.6%, respectively;
Figures 2A,B). In fact, there was no significant difference in
the amount of GFAP+ and MBP+ cells between control media
and PC-CM + anti-Lama2 conditions. Thus, pre-incubation of
PC-CM with an anti-Lama2 antibody prevents the generation of
oligodendrocytes indicating that Lama2 secreted by PCs induces
the fate and differentiation of NSCs towards oligodendrocytes.
DISCUSSION
Besides neurovascular homeostasis, PCs are involved in CNS
repair and regeneration (Lange et al., 2013), particularly,
contributing to oligodendrocyte differentiation during
remyelination (De La Fuente et al., 2017). The latter involves
remodeling of ECM composition, i.e., secretion of Lama2. Here,
we demonstrate that this PC activity is not restricted to OPCs
but also influences NSC fate choice and differentiation. This
might be relevant in CNS remyelination. For example, upon
demyelination in the corpus callosum (CC), NSCs located at the
subependymal zone (SEZ) of the lateral ventricles proliferate
and migrate towards the lesion site and differentiate into
oligodendrocytes (Menn et al., 2006; Etxeberria et al., 2010;
Jablonska et al., 2010; Kazanis et al., 2017). Therefore, PCs
and PC-derived Lama2 may drive this oligodendrocyte fate
decision in SEZ-resident NSCs contributing to newly generated
oligodendrocytes in the CC, however, this assumption should be
further studied in an in vivomodel.
A number of studies have recently addressed the
impact of PCs in CNS pathologies (reviewed in Cheng
et al., 2018). PC deficiency impairs the generation of new
oligodendrocytes during CNS remyelination (De La Fuente
et al., 2017) and human demyelinating MS lesions show a
reduction in pericytes number (Iacobaeus et al., 2017). These
observations together with our recent findings strongly suggest
a regenerative role of these perivascular cells during MS
progression and, therefore, making PCs and Lama2 interesting
therapeutic targets for the development of future MS therapies
(Azevedo et al., 2018).
In summary, we demonstrated that Lama2 secreted by
PCs induces oligodendrocyte fate choice and differentiation
of adult NSCs while it decreases the generation of astrocytes.
Further studies are mandatory to determine the role of PCs
during CNS remyelination in more detail and to pave the way
towards the development of pro-remyelinating therapies for the
treatment of MS.
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